351
Views
37
CrossRef citations to date
0
Altmetric
Review

Early-onset Type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk

&
Pages 315-322 | Published online: 10 Jan 2014
 

Abstract

The age of onset of Type 2 diabetes mellitus (T2DM) is falling and this condition is not uncommon among those aged less than 30 years, including children and adolescents. Early-onset T2DM has been reported in countries with different ethnic and cultural backgrounds. This phenomenon heralds an important public health issue reflecting the effects of a sedentary lifestyle as part of the globalization and industrialization that is affecting all societies. The pathophysiology of early-onset T2DM is similar to the later onset cohort characterized by β-cell failure and obesity-induced insulin resistance but the rate of decline in β-cell function appears to be more rapid. Recent evidence suggests that early-onset T2DM is a more aggressive disease phenotype than the later onset cohort and develops cardiovascular complications, reflected by more adverse cardiovascular risk profile and higher relative risk of myocardial infarction and cardiovascular death. As there is a paucity of clinical trial evidence in this population, clinical judgment is required to initiate treatments to prevent cardiovascular complications guided by assessment of global cardiovascular risk. Future research strategies in this cohort include population-based studies in at-risk populations, exploration of its natural history, development of complications and outcome studies pertaining to the treatment of cardiovascular risk factors.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.